Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.6 Billion CNY | 22.94% |
| 2022 | 4.55 Billion CNY | -16.81% |
| 2021 | 5.47 Billion CNY | 162.96% |
| 2020 | 2.08 Billion CNY | -17.54% |
| 2019 | 2.52 Billion CNY | 47.18% |
| 2018 | 1.71 Billion CNY | -1.82% |
| 2017 | 1.74 Billion CNY | 833.73% |
| 2016 | 187.14 Million CNY | 5.82% |
| 2015 | 176.84 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 64 Million CNY | 0.0% |
| 2011 | 64 Million CNY | 0.0% |
| 2010 | 64 Million CNY | 0.0% |
| 2009 | 64 Million CNY | 0.0% |
| 2008 | 64 Million CNY | 0.0% |
| 2007 | 64 Million CNY | 0.0% |
| 2006 | 64 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.59 Billion CNY | -0.1% |
| 2024 Q2 | 6.79 Billion CNY | 21.48% |
| 2024 Q3 | 757.19 Million CNY | -22.32% |
| 2023 Q1 | 4.88 Billion CNY | 7.15% |
| 2023 Q3 | 4.59 Billion CNY | 0.82% |
| 2023 Q4 | 5.6 Billion CNY | 21.97% |
| 2023 FY | 5.6 Billion CNY | 22.94% |
| 2023 Q2 | 4.55 Billion CNY | -6.71% |
| 2022 Q2 | 5.02 Billion CNY | -5.77% |
| 2022 Q3 | 4.89 Billion CNY | -2.57% |
| 2022 Q1 | 5.33 Billion CNY | -2.56% |
| 2022 FY | 4.55 Billion CNY | -16.81% |
| 2022 Q4 | 4.55 Billion CNY | -7.01% |
| 2021 FY | 5.47 Billion CNY | 162.96% |
| 2021 Q2 | 5.53 Billion CNY | 5.29% |
| 2021 Q4 | 5.47 Billion CNY | 1.74% |
| 2021 Q3 | 5.38 Billion CNY | -2.81% |
| 2021 Q1 | 5.25 Billion CNY | 152.58% |
| 2020 FY | 2.08 Billion CNY | -17.54% |
| 2020 Q4 | 2.08 Billion CNY | -25.61% |
| 2020 Q3 | 2.79 Billion CNY | -34.91% |
| 2020 Q2 | 4.3 Billion CNY | 35.57% |
| 2020 Q1 | 3.17 Billion CNY | 25.61% |
| 2019 FY | 2.52 Billion CNY | 47.18% |
| 2019 Q1 | 2.01 Billion CNY | 17.58% |
| 2019 Q2 | 2.51 Billion CNY | 24.47% |
| 2019 Q3 | 1.95 Billion CNY | -21.94% |
| 2019 Q4 | 2.52 Billion CNY | 28.84% |
| 2018 Q2 | 1.98 Billion CNY | 18.44% |
| 2018 Q4 | 1.71 Billion CNY | -1.19% |
| 2018 FY | 1.71 Billion CNY | -1.82% |
| 2018 Q1 | 1.67 Billion CNY | -3.89% |
| 2018 Q3 | 1.73 Billion CNY | -12.71% |
| 2017 Q1 | 186.47 Million CNY | -0.36% |
| 2017 FY | 1.74 Billion CNY | 833.73% |
| 2017 Q4 | 1.74 Billion CNY | -2.7% |
| 2017 Q3 | 1.79 Billion CNY | 280.64% |
| 2017 Q2 | 471.82 Million CNY | 153.03% |
| 2016 FY | 187.14 Million CNY | 5.82% |
| 2016 Q3 | 175.94 Million CNY | 0.02% |
| 2016 Q2 | 175.9 Million CNY | -0.35% |
| 2016 Q1 | 176.52 Million CNY | -0.18% |
| 2016 Q4 | 187.14 Million CNY | 6.37% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 176.84 Million CNY | 0.0% |
| 2015 Q4 | 176.84 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2013 Q4 | - CNY | -100.0% |
| 2013 Q3 | 64 Million CNY | 0.0% |
| 2013 Q2 | 64 Million CNY | 0.0% |
| 2013 Q1 | 64 Million CNY | 0.0% |
| 2012 Q4 | 64 Million CNY | 0.0% |
| 2012 Q1 | 64 Million CNY | 0.0% |
| 2012 FY | 64 Million CNY | 0.0% |
| 2012 Q2 | 64 Million CNY | 0.0% |
| 2012 Q3 | 64 Million CNY | 0.0% |
| 2011 FY | 64 Million CNY | 0.0% |
| 2011 Q4 | 64 Million CNY | 0.0% |
| 2011 Q2 | 64 Million CNY | 0.0% |
| 2011 Q1 | 64 Million CNY | 0.0% |
| 2011 Q3 | 64 Million CNY | 0.0% |
| 2010 Q2 | 64 Million CNY | 0.0% |
| 2010 Q4 | 64 Million CNY | 0.0% |
| 2010 FY | 64 Million CNY | 0.0% |
| 2010 Q1 | 64 Million CNY | 0.0% |
| 2010 Q3 | 64 Million CNY | 0.0% |
| 2009 FY | 64 Million CNY | 0.0% |
| 2009 Q4 | 64 Million CNY | -23.81% |
| 2009 Q2 | 84 Million CNY | 0.0% |
| 2009 Q3 | 84 Million CNY | 0.0% |
| 2008 Q4 | 64 Million CNY | 0.0% |
| 2008 FY | 64 Million CNY | 0.0% |
| 2007 FY | 64 Million CNY | 0.0% |
| 2006 FY | 64 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 20.2 Billion CNY | 72.286% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 6.25 Billion CNY | 10.459% |